Annovis Bio ANVS
NYSE ANVS
$1.01 +0.03 (+3.26%)
As of: Oct 21, 2026 · 3:59 PM EDT

Annovis Bio (ANVS) Receivables - Other (2019 - 2020)

Updated

Annovis Bio's Receivables - Other came in at $424,952 for Q3 2020, up 113.3% from the prior quarter.

Analysis

Annovis Bio (ANVS) Receivables - Other (2019 - 2020) Analysis & Trends

At the end of FY2019, Annovis Bio's Receivables - Other was $735,075.

  • The five-year range for quarterly Receivables - Other is $37,752 (Q1 2020) to $735,075 (Q4 2019).
  • Business Quant data shows ANVS's Receivables - Other at $199,221 (Q2 2020), $37,752 (Q1 2020) and $735,075 (Q4 2019) in the three quarters before Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Annovis Bio 37.22 Mn -30.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 424,952.00
Jun 30, 2020 199,221.00
Mar 31, 2020 37,752.00
Dec 31, 2019 735,075.00
API Access

Annovis Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANVS&period=max&api_key=YOUR_API_KEY